151 related articles for article (PubMed ID: 17339422)
1. A novel proteoliposomal vaccine induces antitumor immunity against follicular lymphoma.
Neelapu SS; Gause BL; Harvey L; Lee ST; Frye AR; Horton J; Robb RJ; Popescu MC; Kwak LW
Blood; 2007 Jun; 109(12):5160-3. PubMed ID: 17339422
[TBL] [Abstract][Full Text] [Related]
2. Human autologous tumor-specific T-cell responses induced by liposomal delivery of a lymphoma antigen.
Neelapu SS; Baskar S; Gause BL; Kobrin CB; Watson TM; Frye AR; Pennington R; Harvey L; Jaffe ES; Robb RJ; Popescu MC; Kwak LW
Clin Cancer Res; 2004 Dec; 10(24):8309-17. PubMed ID: 15623607
[TBL] [Abstract][Full Text] [Related]
3. A novel proteoliposomal vaccine elicits potent antitumor immunity in mice.
Popescu MC; Robb RJ; Batenjany MM; Boni LT; Neville ME; Pennington RW; Neelapu SS; Kwak LW
Blood; 2007 Jun; 109(12):5407-10. PubMed ID: 17351111
[TBL] [Abstract][Full Text] [Related]
4. Translational development of vaccination strategies in follicular NHL.
Sakamaki I; Qin H; Kwak LW
Best Pract Res Clin Haematol; 2011 Jun; 24(2):295-304. PubMed ID: 21658625
[TBL] [Abstract][Full Text] [Related]
5. Clinical benefit associated with idiotypic vaccination in patients with follicular lymphoma.
Inogès S; Rodrìguez-Calvillo M; Zabalegui N; Lòpez-Dìaz de Cerio A; Villanueva H; Soria E; Suárez L; Rodríguez-Caballero A; Pastor F; García-Muñóz R; Panizo C; Pèrez-Calvo J; Melero I; Rocha E; Orfao A; Bendandi M; ;
J Natl Cancer Inst; 2006 Sep; 98(18):1292-301. PubMed ID: 16985248
[TBL] [Abstract][Full Text] [Related]
6. Idiotype vaccine strategies for improving outcomes in follicular lymphoma.
Sinha R; Shenoy PJ; Flowers CR
Expert Opin Biol Ther; 2008 Aug; 8(8):1213-23. PubMed ID: 18613772
[TBL] [Abstract][Full Text] [Related]
7. Autologous lymphoma vaccines induce human T cell responses against multiple, unique epitopes.
Baskar S; Kobrin CB; Kwak LW
J Clin Invest; 2004 May; 113(10):1498-510. PubMed ID: 15146248
[TBL] [Abstract][Full Text] [Related]
8. Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma.
Bendandi M; Gocke CD; Kobrin CB; Benko FA; Sternas LA; Pennington R; Watson TM; Reynolds CW; Gause BL; Duffey PL; Jaffe ES; Creekmore SP; Longo DL; Kwak LW
Nat Med; 1999 Oct; 5(10):1171-7. PubMed ID: 10502821
[TBL] [Abstract][Full Text] [Related]
9. Anti-idiotypic Immunotherapy in follicular lymphoma patients: results of a long follow-up study.
Yáñez R; Barrios Y; Ruiz E; Cabrera R; Díaz-Espada F
J Immunother; 2008 Apr; 31(3):310-2. PubMed ID: 18317357
[TBL] [Abstract][Full Text] [Related]
10. Anti-idiotype vaccines for human follicular lymphoma.
Bendandi M
Leukemia; 2000 Aug; 14(8):1333-9. PubMed ID: 10942225
[TBL] [Abstract][Full Text] [Related]
11. Sequential intranodal immunotherapy induces antitumor immunity and correlated regression of disseminated follicular lymphoma.
Kolstad A; Kumari S; Walczak M; Madsbu U; Hagtvedt T; Bogsrud TV; Kvalheim G; Holte H; Aurlien E; Delabie J; Tierens A; Olweus J
Blood; 2015 Jan; 125(1):82-9. PubMed ID: 25293773
[TBL] [Abstract][Full Text] [Related]
12. Vaccination strategies in follicular lymphoma.
Kannan S; Neelapu SS
Curr Hematol Malig Rep; 2009 Oct; 4(4):189-95. PubMed ID: 20425407
[TBL] [Abstract][Full Text] [Related]
13. Role of anti-idiotype vaccines in the modern treatment of human follicular lymphoma.
Bendandi M
Expert Rev Anticancer Ther; 2001 Jun; 1(1):65-72. PubMed ID: 12113135
[TBL] [Abstract][Full Text] [Related]
14. Idiotype vaccine strategies for treatment of follicular lymphoma.
Mahaseth H; Brody JD; Sinha R; Shenoy PJ; Flowers CR
Future Oncol; 2011 Jan; 7(1):111-22. PubMed ID: 21174542
[TBL] [Abstract][Full Text] [Related]
15. Prolonged idiotypic vaccination against follicular lymphoma.
Inoges S; Lopez-Diaz de Cerio A; Zabalegui N; Soria E; Villanueva H; Panizo C; Rodriguez-Caballero A; Suarez L; Pastor F; Rodriguez-Calvillo M; Orfao A; Bendandi M
Leuk Lymphoma; 2009 Jan; 50(1):47-53. PubMed ID: 19152172
[TBL] [Abstract][Full Text] [Related]
16. Recombinant, tumour-derived idiotype vaccination for indolent B cell non-Hodgkin's lymphomas: a focus on FavId.
Hurvitz SA; Timmerman JM
Expert Opin Biol Ther; 2005 Jun; 5(6):841-52. PubMed ID: 15952914
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic lymphoma vaccines: importance of T-cell immunity.
Neelapu SS; Lee ST; Qin H; Cha SC; Woo AF; Kwak LW
Expert Rev Vaccines; 2006 Jun; 5(3):381-94. PubMed ID: 16827622
[TBL] [Abstract][Full Text] [Related]
18. Active immunotherapy in follicular lymphoma.
Veelken H
Semin Cancer Biol; 2003 Jun; 13(3):241-7. PubMed ID: 12959355
[TBL] [Abstract][Full Text] [Related]
19. BiovaxID idiotype vaccination: active immunotherapy for follicular lymphoma.
Flowers CR
Expert Rev Vaccines; 2007 Jun; 6(3):307-17. PubMed ID: 17542746
[TBL] [Abstract][Full Text] [Related]
20. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]